Tracheostomy in motor neurone disease
- 4 July 2019
- journal article
- review article
- Published by BMJ in Practical Neurology
- Vol. 19 (6) , 467-475
Abstract
Tracheostomy-associated ventilation for the respiratory insufficiency caused by amyotrophic lateral sclerosis (motor neurone disease (MND)) is a complex issue with practical, ethical and economic dimensions. This article considers the current prevalence of tracheostomy in MND, the evidence for its benefit both for survival and quality of life, and the practicalities of its implementation. The decision to request invasive ventilatory support is among the most challenging for those living with MND. Neurologists should be prepared to discuss this option openly and objectively: we suggest a framework for discussion, including withdrawal of therapy.Keywords
This publication has 52 references indexed in Scilit:
- Amyotrophic lateral sclerosis: the complex path to precision medicineJournal of Neurology, 2018
- Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patientsPLOS ONE, 2017
- Dysfunction of central control of breathing in amyotrophic lateral sclerosisMuscle & Nerve, 2017
- Todesursachen bei amyotropher LateralskleroseDer Nervenarzt, 2017
- Gene discovery in amyotrophic lateral sclerosis: implications for clinical managementNature Reviews Neurology, 2016
- A wider pathological network underlying breathlessness and respiratory failure in amyotrophic lateral sclerosisEuropean Respiratory Journal, 2016
- Some difficult decisions in ALS/MNDAmyotrophic Lateral Sclerosis, 2010
- Causes and place of death in Italian patients with amyotrophic lateral sclerosisActa Neurologica Scandinavica, 2010
- Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective studyEuropean Journal of Neurology, 2008
- Causes of death in a post‐mortem series of ALS patientsAmyotrophic Lateral Sclerosis, 2008